MedPath
NMPA Approval

Tirofiban Hydrochloride Injection

国药准字H20223802

November 1, 2022

Drug Information

盐酸替罗非班注射液

注射剂

15ml:3.75mg(按C₂₂H₃₆N₂O₅S计)

化学药品

November 1, 2022

Company Information

Applicant Company

成都高新区冯家湾工业园科园南路88号B7栋5楼

Manufacturing Company

成都高新西区西部园区西芯大道15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸替罗非班注射液 - NMPA 批准文号 | MedPath